A groundbreaking study published by researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center has demonstrated that pleurectomy/decortication, the less aggressive, lung-sparing surgery for pleural mesothelioma patients, can be performed safely, with remarkably low mortality rates, when patients are carefully selected. These findings, which contradict those of
A report published by the European Union’s statistical office demonstrates that mesothelioma accounted for 16,469 of the 40,538 occupational cancer cases officially recognized in the European Union between 2013 and 2023. The report issued by Eurostat shows that despite steps taken to minimize asbestos exposure, the rare disease represents 40.6 percent of all diagnosed work-related
Malignant pleural mesothelioma is a notoriously difficult form of cancer to treat. The aggressive, asbestos-related disease is always considered fatal, with most patients succumbing to their illness within a year of diagnosis. However, the Froedtert & the Medical College of Wisconsin health network recently reported good results after treating a patient with immunotherapy drugs.
Mesothelioma is one of the most challenging forms of cancer to treat. The aggressive disease has proven resistant to traditional protocols and is always considered fatal. This week a study reveals a new way to combat therapy-resistant cancers, and mesothelioma researchers are hoping that it can be applied to the rare and deadly asbestos-related malignancy.
The Peter MacCallum Cancer Center is a renowned cancer treatment center that has been a leader in mesothelioma research. Located in Melbourne, Australia, the facility affectionately referred to as “Peter Mac” is credited with several breakthroughs in cancer treatment, including having discovered the “Hippo” signaling pathway that holds promise for a better understanding of the
Pulmonologists are physicians with expert knowledge of the respiratory system. They are often the specialists that primary care physicians turn to when their patients are experiencing pleural effusion and other mesothelioma symptoms. Pulmonologists’ expertise in lung function makes them critical members of any pleural mesothelioma multidisciplinary treatment team. What Is a Pulmonologist? A pulmonologist is
Virginia Cancer Specialists offers a complete spectrum of care for patients with pleural mesothelioma and lung cancer. Based in Fairfax, Virginia, the organization provides patients with state-of-the-art treatment options in a convenient location. Patients also have unique access to research and clinical trials.
West Cancer Center & Research Institute is a comprehensive cancer center located in Memphis, Tennessee. Its physicians and researchers are dedicated to the delivery of cutting-edge, compassionate cancer care for patients diagnosed with cancers of all types, including malignant peritoneal and pleural mesothelioma and lung cancer.
Massachusetts General Cancer Center in Boston, Massachusetts. It is a leading cancer center recognized for patient care and research, including its care of those diagnosed with thoracic cancers like lung cancer and malignant pleural mesothelioma.
Tufts Medical Center Cancer Center is at the forefront of the diagnosis and treatment of malignant mesothelioma and lung cancer. Located in Boston, Massachusetts, Tufts is also a leader in innovative research.